Follow The Filings

Pfizer Inc.

New York, NY 4 processed 13Fs on this site, 2025 Q3 to 2026 Q2

  • $170M
  • 17 holdings
  • 2026 Q2
  • −28.9% QoQ
  • Top 5 78.9%

Portfolio

2026 Q2, filed 8/13/2026, top 12 of 17 holdings

Top 5 78.9%, top 10 95.7%

  1. ALLO, Allogene Therapeutics 27.6%
  2. CELC, Celcuity 17.3%
  3. ARVN, Arvinas 16.2%
  4. PYXS, Pyxis Oncology 11.4%
  5. WVE, Wave Life Sciences 6.4%
  6. BHVN, Biohaven 4.7%
  7. CRBU, Caribou Biosciences 4.6%
  8. Spero Therapeutics 3.1%
  9. ZNTL, Zentalis Pharmaceuticals 2.3%
  10. ORIC, Oric Pharmaceuticals 2.1%
  11. CRDF, Cardiff Oncology 1.8%
  12. ZURA, Zura Bio 1.7%
  13. Other 0.8%

AUM over time

2026 Q2 $170M −28.9% QoQ
2025 Q3: $437M 2025 Q3: $437M
Q3 2025
2025 Q4: $236M, −46.0% QoQ 2025 Q4: $236M, −46.0% QoQ
Q4
2026 Q1: $239M, +1.3% QoQ 2026 Q1: $239M, +1.3% QoQ
Q1 2026
2026 Q2: $170M, −28.9% QoQ 2026 Q2: $170M, −28.9% QoQ
Q2

Book

2025 Q3, filed 13 Nov, long equity only

Download CSV Download Excel
BNTX, Biontech 37.39% Hold 1,658,361 $98.62 $164M
ORIC, Oric Pharmaceuticals 14.75% Hold 5,376,344 $12.00 $65M
Tourmaline Bio 13.91% Hold 1,272,214 $47.83 $61M
ARVN, Arvinas 6.73% Hold 3,457,815 $8.52 $29M
ALLO, Allogene Therapeutics 6.25% Hold 22,032,040 $1.24 $27M
CELC, Celcuity 3.95% Hold 349,406 $49.40 $17M
PYXS, Pyxis Oncology 3.57% Hold 7,032,770 $2.22 $16M
WVE, Wave Life Sciences 3.14% Hold 1,875,000 $7.32 $14M
ZURA, Zura Bio 2.94% Hold 2,970,022 $4.33 $13M
CRBU, Caribou Biosciences 2.50% Hold 4,690,431 $2.33 $11M
BHVN, Biohaven 1.73% Hold 505,645 $15.01 $7.6M
CRDF, Cardiff Oncology 1.14% Hold 2,411,575 $2.06 $5M
Spero Therapeutics 1.02% Hold 2,362,348 $1.88 $4.4M
ZNTL, Zentalis Pharmaceuticals 0.33% Hold 953,834 $1.51 $1.4M
NXTC, Nextcure 0.21% Hold 157,646 $5.86 $924K
ANTX, An2 Therapeutics 0.21% Hold 715,295 $1.27 $908K
QTTB, Q32 Bio 0.13% Hold 277,777 $1.98 $550K
Holding 0.07% Hold 1,675,000 $0.1910 $320K
BOLT, Bolt Biotherapeutics 0.04% Hold 31,305 $5.32 $167K
DNA, Ginkgo Bioworks 0.01% Hold 2,928 $14.58 $43K
Senseonics 0.00% Hold 43,426 $0.4360 $19K

* Reported price is value ÷ shares from the 13F as of period end, not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Click a column header to sort, or New, Hold, Add or Reduce to bring those moves to the top.

Filings history

4 periods, with AUM normalized

Newest 13Fs
Period Holds AUM QoQ Form Filed Filing ID
2026 Q2 17 $170M −28.9% 13F-HR 8/13/2026 000007800326000102
2026 Q1 18 $239M +1.3% 13F-HR 5/12/2026 000007800326000064
2025 Q4 18 $236M −46.0% 13F-HR 2/12/2026 000007800326000013
2025 Q3 21 $437M — 13F-HR 11/13/2025 000007800325000161

About

Pfizer Inc.

4 processed 13Fs on this site, 2025 Q3 to 2026 Q2

SEC filing name
PFIZER INC
Location
New York, NY
All SEC filings
View on sec.gov

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

  • The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
  • One Up On Wall Street (Lynch), Peter Lynch View on Amazon

More on the shelf